| The law of genetic privacy: applications, implications, and limitations |
21 |
| CRISPR'd babies: human germline genome editing in the 'He Jiankui affair' |
19 |
| May your drug price be evergreen |
10 |
| GINA at 10 years: the battle over 'genetic information' continues in court |
8 |
| Cutting edges and weaving threads in the gene editing ((sic))evolution: reconciling scientific progress with legal, ethical, and social concerns |
5 |
| Creating life after death: should posthumous reproduction be legally permissible without the deceased's prior consent? |
5 |
| State incentives to promote organ donation: honoring the principles of reciprocity and solidarity inherent in the gift relationship |
5 |
| Integrating artificial intelligence into health care through data access: can the GDPR act as a beacon for policymakers? |
4 |
| Open forensic science |
4 |
| Time to rethink the law on part-human chimeras |
4 |
| The generic drug user fee amendments: an economic perspective |
4 |
| The app will see you now: mobile health, diagnosis, and the practice of medicine in Quebec and Ontario |
4 |
| Patenting nature-a comparative perspective |
3 |
| Uterus transplantation in and beyond cisgender women: revisiting procreative liberty in light of emerging reproductive technologies |
2 |
| The brain in solitude: an (other) eighth amendment challenge to solitary confinement |
2 |
| Political economy, stakeholder voices, and saliency: lessons from international policies regulating insurer use of genetic information |
2 |
| The stem cell market and policy options: a call for clarity |
2 |
| Present-day posthumous reproduction and traditional levirate marriage: two types of interactions |
1 |
| The impact of virtual reality on implicit racial bias and mock legal decisions |
1 |
| Genetic research and applicable law: the intra-EU conflict of laws as a regulatory challenge to cross-border genetic research |
1 |
| Addressing the needs of Canadians with rare diseases: an evaluation of orphan drug incentives |
1 |
| Assessing the legal duty to use or disclose interim data for ongoing clinical trials |
1 |
| Alzheimer's disease biomarkers: another tool for FAA pilot screening? |
1 |
| Coercive neuroimaging, criminal law, and privacy: a European perspective |
1 |
| Judging homicide defendants by their brains: an empirical study on the use of neuroscience in homicide trials in Slovenia |
1 |
| The doctor as jailer: medical detention of non-psychiatric patients |
1 |
| The tyranny of choice: reproductive selection in the future |
1 |
| A clash at the petri dish: transferring embryos with known genetic anomalies |
1 |
| Surrogacy, privacy, and the American Convention on Human Rights |
1 |
| Suicide and Death with Dignity |
1 |
| Privatizing procreative liberty in the shadow of eugenics |
0 |
| Assessing potential legal responses to medical ghostwriting: effectiveness and constitutionality |
0 |
| A critique of national solidarity in transnational organ sharing in Europe |
0 |
| Neuroscience, criminal responsibility and sentencing in an islamic country: Iran |
0 |
| Protecting essential information about genetic variants as trade secrets: a problem for public policy? |
0 |
| Disparate impacts and GINA: Congress's unfinished business |
0 |
